Torque Teno virus (TTV) is a transfusion transmitted virus that seems to be involved in several complications such as acute respiratory diseases, liver diseases, AIDS, cancer, and autoimmune reactions. In the present study the frequency of TTV was investigated among β-thalassemia (BT) and haemodialysis (HD) patients (high risk patients for TTV) in Mazandaran province, Iran. DNA was extracted from the serum of 82 BT and 100 HD patients, and nested PCR method was applied to detect TTV DNA. The aspartate transaminase(AST) and alanine transaminase (ALT) enzyme levels in BT patients were measured using photometric assay. The mean age of BT and HD patients as 23.4±5.4 and 48.8±8.2 years, respectively. 21% of HD and 26.8% of BT patients were infected with TTV, respectively. The frequency of TTV was not significantly different between two groups of patients and there was no significant correlation between sex and TTV infection. The mean AST and ALT levels in TTV positive BT patients was not significantly higher than TTV negative cases. The present study showed that TTV prevalence in BT patients with recurrent blood transfusion was not significantly higher than HD patients. The investigation of TTV prevalence in healthy individuals is recommended to identify if transfusion or dialysis is associated with higher TTV infection. Besides, although TTV infection did not change the AST and ALT enzymes in BT patients, the liver involvement may still exist in these patients.
TV (Torque Teno Virus) is a single strand DNA virus that was detected for the first time in a Japanese man with non A-G hepatitis at 1997 (1) . The genome of the virus is 3.8 Kb long containing 2.6 kb of coding regions that translate 3 or more proteins (2) (3) (4) . At first, it seemed that the virus was associated with hepatitis, but numerous studies showed that it was present in more than 50% of apparently healthy subjects in some populations (5, 6) . However, the pathogenic role of TTV is not well understood. TTV is suggested to be involved in several diseases such as acute respiratory diseases (7), liver diseases (5, 6), AIDS (8) , cancer (9) , and autoimmune reactions (10) .
Nonetheless, convincing evidence that support the role of TTV in the mentioned disorders have not been reported. Since TTV has a great variety of genotypes (11) , some genotypes may be responsible for pathogenesis of the virus.
Beta-thalassemia (BT) is one of the most common genetic disorders and a serious health problem in Iran, especially in Mazandaran province (12) (13) (14) . Recurrent blood transfusion is the main treatment for improving clinical manifestation of the disease (15) . In patients with chronic transfusion regimes, liver diseases that are mostly caused by the agents transmitted by blood products and concomitant iron liver siderosis are common.
Although new viral agents and TTV are identified in these patients, their association with any disease has not been reported (16) .
Infections are the major causes of mortality and morbidity in haemodialysis (HD) patients.
Hence, the patients with chronic renal failure (CRF) undergoing HD are at risk of TTV infection and are suffering from mentioned complications (17) .
The aim of the present study was to investigate the frequency of TTV in two groups of BT and HD patients in North of Iran.
Materials and methods
Eighty two BT and 100 HD patients were enrolled in the study in Mazandaran province in northern Iran. The BT patients that underwent recurrent blood transfusion therapy, registered at Thalassemia Research Center at Boali hospital, Sari, Iran, with haemoglobin (Hb) levels less than 9 g/dl, were included in the study.Likewise the HD patients with CRF registered at dialysis ward of Fatemeh Zahra hospital, Sari, Iran were also included in the study. The intermediate BT patients
with Hb more than 9 g/dl that were independent of blood transfusion were excluded from the study. 
Results
Eighty-two BT patients including 38 (46%) male and 44 (54%) female cases and 100 HD patients including 41 (41%) female and 59 (59%) male subjects were studied. The mean age of BT with TTV and similar to the present study, there was no association between TTV and ALT levels (21) . In Isfahan province, the prevalence of TTV in injection drug users (58%) was significantly higher than HD patients (17 %) and healthy individuals (8%) (22) .
Several studies indicated that TTV was highly present in BT patients in Turkey (23) (61%) and Italy (73% in the BT children and 69.1% in adult BT) (24, 25) . These results suggest that TTV-DNA is transmitted to the recipients by blood and blood products. So, blood transfusion is one of the most ways for TTV transmission.
In Saudi Arabia, the prevalence of TTV in HD patients was high and statistically significant; 
